The European Commission announced on Monday the approval of the BioNTech / Pfizer adapted vaccine against current variants of the coronavirus, including omicron. “This will help us be more confident this fall. Vaccination remains the best way to protect yourself from the coronavirus “, explained the president of the European Commission, Ursula von der Leyenin a message posted on Twitter.
This vaccine is designed to better match circulating variants of SARS-CoV-2 and therefore can expand protection against different variants, thus helping to maintain optimal protection against to Covid-19 with the evolution of the virus.
The decision is supported by the recommendation of the European Medicines Agency (EMA), which published a report on 1 September favorable for both Pfizer and Moderna vaccines.
The United States Food and Drug Administration (FDA) has already approved the use of two BA.4 / BA.5 vaccines for emergency use in late August.
–
